Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe SARS-CoV2 Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04874740
What this trial is testing

Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region

Who this might be right for
COVID-19 PandemicTransplantation, Kidney
University Hospital Ostrava 300
Large-scale testing (Phase 3)Ended earlyNCT04421508
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

Who this might be right for
COVID-19CoronavirusCoronavirus Infection
Bellerophon Pulse Technologies 191
Testing effectiveness (Phase 2)Study completedNCT04366908
What this trial is testing

Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome

Who this might be right for
SARS-CoV 2COVID19SARS (Severe Acute Respiratory Syndrome)+2 more
Maimónides Biomedical Research Institute of Córdoba 517
Large-scale testing (Phase 3)Ended earlyNCT04449588
What this trial is testing

Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS

Who this might be right for
COVID-19 Pneumonia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 369
Early research (Phase 1)UnknownNCT04474340
What this trial is testing

COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients

Who this might be right for
Moderate COVID-19 Pneumonia, Severe COVID-19 PneumoniaPneumonia, Viral
Ministry of Health, Kuwait 300
Large-scale testing (Phase 3)Ended earlyNCT05254990
What this trial is testing

Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Who this might be right for
Infectious PneumoniaSevere COVID-19
Dompé Farmaceutici S.p.A 414
Not applicableStudy completedNCT04354610
What this trial is testing

Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection

Who this might be right for
COVID 19
Central Hospital, Nancy, France 73
Not applicableStudy completedNCT07261085
What this trial is testing

Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.

Who this might be right for
COVID-19
Pfizer 99,000
Not applicableStudy completedNCT04995289
What this trial is testing

Prone Position During ECMO in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hypoxaemic Patient

Who this might be right for
SARS CoV 2 InfectionHypoxemic Respiratory Failure
Mohammed VI University Hospital 23
Testing effectiveness (Phase 2)Ended earlyNCT04547140
What this trial is testing

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Grifols Therapeutics LLC 57
Testing effectiveness (Phase 2)Ended earlyNCT05659459
What this trial is testing

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2

Who this might be right for
COVID-19
Kinarus AG 17
Large-scale testing (Phase 3)UnknownNCT04703608
What this trial is testing

Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia

Who this might be right for
Covid-19
London School of Hygiene and Tropical Medicine 1,200
Early research (Phase 1)UnknownNCT04747574
What this trial is testing

Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection

Who this might be right for
SARS-CoV-2
Tel-Aviv Sourasky Medical Center 35
Not applicableStudy completedNCT04981249
What this trial is testing

Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection

Who this might be right for
Covid-19Chronic Disease
Corporacion Parc Tauli 14,286
Not applicableActive Not RecruitingNCT05467917
What this trial is testing

ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases

Who this might be right for
COVID-19HouseholdsSARS CoV 2 Infection
Columbia University 374
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Study completedNCT04494984
What this trial is testing

Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Who this might be right for
COVID-19
Inmunova S.A. 243
Not applicableLooking for participantsNCT04582903
What this trial is testing

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Who this might be right for
COVID-19 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Large-scale testing (Phase 3)Study completedNCT04467840
What this trial is testing

Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

Who this might be right for
COVID-19Lung Infection
RedHill Biopharma Limited 475
Not applicableStudy completedNCT04610554
What this trial is testing

Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19

Who this might be right for
COVID-19 Pneumonia
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 74
Next Page